Literature DB >> 16840586

Immunochemistry of lysosomal storage disorders.

Emma Parkinson-Lawrence1, Maria Fuller, John J Hopwood, Peter J Meikle, Doug A Brooks.   

Abstract

BACKGROUND: Lysosomal storage disorders are a group of genetic diseases, each with a broad spectrum of clinical presentation that ranges from attenuated to severe. The immunochemical analysis of patient samples is aimed at several key aspects of patient management, including early detection of the disorder, prediction of clinical severity, determining the most appropriate therapeutic regimen, and monitoring of patients on therapy.
METHODS: In this study, we review the current and emerging technology available to achieve these assessments.
RESULTS: Immune assays have direct practical application for the early detection, diagnosis and prognosis of lysosomal storage disorder patients. Multiplexing of these assays may provide a platform to allow newborn screening for multiple lysosomal storage disorders.
CONCLUSIONS: We have reviewed the immunochemical techniques available for the analysis of lysosomal storage disorder patient samples and advise that these may be used in conjunction with other technologies for effective patient management.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840586     DOI: 10.1373/clinchem.2005.064915

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

Review 1.  Newborn Screening for Lysosomal Storage Disorders.

Authors:  Roy W A Peake; Olaf A Bodamer
Journal:  J Pediatr Genet       Date:  2016-12-02

Review 2.  Newborn screening for lysosomal storage disorders and other neuronopathic conditions.

Authors:  Dietrich Matern; Devin Oglesbee; Silvia Tortorelli
Journal:  Dev Disabil Res Rev       Date:  2013

Review 3.  Newborn screening and diagnosis of mucopolysaccharidoses.

Authors:  Shunji Tomatsu; Tadashi Fujii; Masaru Fukushi; Toshihiro Oguma; Tsutomu Shimada; Miho Maeda; Kazuhiro Kida; Yuniko Shibata; Hideyuki Futatsumori; Adriana M Montaño; Robert W Mason; Seiji Yamaguchi; Yasuyuki Suzuki; Tadao Orii
Journal:  Mol Genet Metab       Date:  2013-06-21       Impact factor: 4.797

4.  A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan.

Authors:  Shuan-Pei Lin; Hsiang-Yu Lin; Tuen-Jen Wang; Chia-Ying Chang; Chia-Hui Lin; Sung-Fa Huang; Chia-Chen Tsai; Hsuan-Liang Liu; Joan Keutzer; Chih-Kuang Chuang
Journal:  Orphanet J Rare Dis       Date:  2013-09-22       Impact factor: 4.123

5.  Bio-Plex immunoassay measuring the quantity of lysosomal N-acetylgalactosamine-6-sulfatase protein in dried blood spots for the screening of mucopolysaccharidosis IVA in newborn: a pilot study.

Authors:  Chih-Kuang Chuang; Hsiang-Yu Lin; Tuan-Jen Wang; Sung-Fa Huang; Shuan-Pei Lin
Journal:  BMJ Open       Date:  2017-07-13       Impact factor: 2.692

Review 6.  Calcium signaling via two-pore channels: local or global, that is the question.

Authors:  Michael X Zhu; Jianjie Ma; John Parrington; Peter J Calcraft; Antony Galione; A Mark Evans
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-16       Impact factor: 4.249

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.